AISAP Cardio vs Acumen Hypotension Prediction Index (HPI) Feature Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AISAP Cardio

by AISAP

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

AI Verdict

Tool A focuses on AI-powered interpretation of point-of-care ultrasound for rapid cardiac diagnostic assessments and early detection of structural heart disease. In contrast, Tool B utilizes machine learning to predict hypotensive events up to 15 minutes in advance, enabling proactive hemodynamic management. While both contribute to cardiology care, Tool A serves diagnostic purposes for chronic conditions, whereas Tool B is a predictive monitoring tool for acute hemodynamic instability.

Choose AISAP Cardio if…

Choose AISAP Cardio if your priority is rapid, comprehensive cardiac diagnostic assessment and measurement at the point of care. This tool is best suited for clinicians needing AI-powered interpretation to quickly detect structural heart disease or heart failure, generate automated reports, and assess key cardiac parameters directly at the bedside. It streamlines early cardiac evaluation and integrates with existing clinical workflows.

View AISAP Cardio →

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) if your primary goal is proactive hemodynamic management and the prevention of hypotensive events in critically ill or surgical patients. This software is ideal for settings where continuous monitoring and early alerts for impending hypotension are crucial, allowing clinicians to intervene up to 15 minutes before an event occurs and optimize patient outcomes. It provides predictive insights into hemodynamic instability.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AISAP Cardio	Acumen Hypotension Prediction Index (HPI) Feature Software
Pricing	Unknown	Contact vendor
Deployment	Cloud-based	Integrated into Edwards Lifesciences HemoSphere advanced monitoring platform.
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AISAP Cardio

AISAP Cardio is designed for rapid, AI-powered cardiac diagnostic assessments directly at the patient's bedside, empowering various clinicians, including non-cardiologists. Its vendor-agnostic nature and seamless integration with existing clinical workflows, EHR/EMR, and PACS suggest broader accessibility and ease of use in diverse clinical settings.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

While both tools are FDA-cleared and offer significant clinical value, Acumen HPI has demonstrated a '57% reduction in duration of intraoperative hypotension' and a 'statistically significant reduction in hypotension vs. standard of care' in clinical studies. This direct, measurable impact on patient outcomes, particularly in preventing critical events, gives it a stronger edge in demonstrated clinical value.

Pricing & Value

Tie

Neither AISAP Cardio nor Acumen HPI provides publicly available pricing information. Without transparent pricing details, it is impossible to conduct a meaningful comparison of their value propositions.

Enterprise Readiness

AISAP Cardio

AISAP Cardio is explicitly stated as a HIPAA-compliant, cloud-based SaaS platform that is vendor-agnostic and integrates seamlessly with existing EHR/EMR and PACS systems. This broad compatibility and explicit compliance make it highly adaptable for diverse enterprise IT environments. While Tool B is also HIPAA compliant and offers a BAA, its integration into a specific proprietary platform might limit its flexibility for enterprises not already invested in that ecosystem.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI is described as a 'first-of-its-kind technology' that uses machine learning to predict hypotensive events up to 15 minutes before they occur. This proactive, predictive capability for a critical clinical event represents a higher level of innovation in real-time patient management, moving beyond interpretation to enable preemptive intervention.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer sufficient public information regarding dedicated support channels, comprehensive documentation libraries, or structured training programs for either AISAP Cardio or Acumen HPI. Therefore, it is not possible to differentiate between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AISAP Cardio	Acumen Hypotension Prediction Index (HPI) Feature Software
Name	AISAP Cardio	Acumen Hypotension Prediction Index (HPI) Feature Software
Company	Aisap	Edwards Lifesciences
Description	FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside.	Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes.
Key Features	AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports, assessment of valvular pathologies, measurement of Left Ventricle Ejection Fraction (LVEF), measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter, vendor-agnostic and scalable solution.	Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen for impending hypotensive events, Relationship View screen providing insights into preload, afterload, and contractility, machine learning algorithms for predictive analysis of blood pressure waveforms, predicts hypotension up to 15 minutes before an event, demonstrated reduction in incidence, duration, and severity of intraoperative hypotension, compatibility with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring, adjustable Mean Arterial Pressure (MAP) target for hypotension definition.
Specialties	Cardiology, Emergency Medicine, Radiology, Critical Care, Internal Medicine, Hospitalists, Primary Care.	Anesthesiology, Critical Care, Emergency Medicine.

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and Acumen Hypotension Prediction Index (HPI) Feature Software.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical objectives of AISAP Cardio compared to Acumen HPI?

AISAP Cardio focuses on providing rapid, comprehensive cardiac diagnostic assessments and measurements at the bedside for early detection of structural heart disease and heart failure. Acumen HPI, in contrast, is designed as a predictive monitoring tool to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management.

What types of patient data do these tools analyze to generate their insights?

AISAP Cardio utilizes AI-powered analysis of point-of-care ultrasound (POCUS) images to assess cardiac structures and function. Acumen HPI employs machine learning algorithms to analyze blood pressure waveforms, predicting hypotensive events up to 15 minutes in advance.

What specific measurements or predictive insights do physicians gain from each tool?

AISAP Cardio provides measurements such as Left Ventricle Ejection Fraction (LVEF), ventricular dimensions, atrial areas, ascending aorta diameter, IVC diameter, and assessments of valvular pathologies. Acumen HPI offers a Hypotension Prediction Index (HPI) score (0-100), Smart Alerts for impending hypotensive events, and a Relationship View providing insights into preload, afterload, and contractility.

In which clinical specialties or settings are these tools primarily intended for use?

AISAP Cardio is relevant for Cardiology, Emergency Medicine, and Radiology, enabling rapid bedside cardiac assessments. Acumen HPI is primarily used in Anesthesiology, Critical Care, and Emergency Medicine for managing hemodynamic instability in surgical and non-surgical patients.

How do these tools contribute to proactive patient care?

AISAP Cardio enables proactive care through early detection of structural heart disease and heart failure by providing rapid, comprehensive cardiac diagnostic assessments at the bedside. Acumen HPI facilitates proactive hemodynamic management by predicting hypotensive events up to 15 minutes before they occur, allowing clinicians to intervene preventatively.